Thomas Andrew Davis Insider Profile
4 Followers
Thomas Andrew Davis, Executive VP & CMO at Celldex, holds 68.33K shares in Genocea Biosciences (Ticker: GNCAQ), holds 1.01K shares in Celldex (Ticker: CLDX), holds 5.00K shares in GenVec Inc (Ticker: GNVC). Most recently, Thomas Andrew Davis Sold ― shares of Genocea Biosciences on Apr 05, 2022 for an estimated value of $1.36K.
Thomas Andrew Davis's Trading History
| GNCAQGenocea Biosciences | Apr 05, 2022 | ― | Informative Sell | 1.36K | ― | |
| CLDXCelldex | Sep 17, 2010 | Executive VP & CMO | Informative Buy | 9.44K | $28.90K | |
| GNVCGenVec Inc | ― | ― | ― | $35.97K |
You May Also Like
Thomas Andrew Davis insider profile FAQ
What stocks does Thomas Andrew Davis hold?
Thomas Andrew Davis holds: CLDX, GNCAQ, GNVC stocks.
What was Thomas Andrew Davis’s latest transaction?
Thomas Andrew Davis’s latest transaction was an Informative Sell of $1.36K.
What is Thomas Andrew Davis's role in Celldex?
Thomas Andrew Davis's role in Celldex is Executive VP & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
